期刊文献+

胆囊癌淋巴转移的临床病理危险因素 被引量:13

Clinicopathologic risk factors for lymph node metastasis in gallbladder carcinoma
下载PDF
导出
摘要 目的探讨胆囊癌淋巴转移的临床病理危险因素。方法回顾性分析医院2010年7月~2012年2月收治的61例胆囊癌患者的临床病理资料。分析胆囊癌淋巴转移与临床病理因素之间的关系。结果 61例患者中,有淋巴转移者50例(62.3%)。单因素分析显示,患者术前血清CEA水平、肿瘤部位、肿瘤大小、组织分化程度、T分期与胆囊癌神经及脉管浸润转移有关(P≤0.05),患者的性别、年龄、是否合并胆囊结石、术前血清CA19-9水平均与胆囊癌淋巴转移无关(P>0.05)。多因素Logistic回归分析显示,肿瘤大小和T分期与胆囊癌淋巴转移相关(P<0.05)。结论肿瘤部位和T分期是影响胆囊癌淋巴转移的独立危险因素。 [Objective] To investigate the risk factors associated with the lymph node metastasis in pa- tients with gallbladder carcinoma. [Methods] The clinical data of 61 patients with gallbladder carcinoma be- tween July 2010 and February 2012 were retrospectively analyzed. The correlation between clinicopathological characteristics and the lymph node metastasis was assessed by univariate and multivariate analyses. [Results] The proportion of patients with Lymph node metastasis out of 61 patients was 62.3% (n =38). Univariate anal- ysis showed that the Serum carcinoembryonic antigen (CEA) level, tumor location, tumor size, differentiation and Pathologic T stage were associated with the lymph node metastasis; the gender, age, pathology, differentia- tion, lymph node metastasis and serum carbohydrate antigenic determinant 19-9 (CA19-9) level before opera- tion were not associated with the lymph node metastasis (P 〉0.05). Multivariate logistic regression analysis showed that the tumor size and the pathologic T stage were significant independent risk factors (P 〈0.05) for lymph node metastasis, with odds ratio of 1.89 and 2.14, respectively. [Conclusion] Tumor location and pathologic T stage are independent risk factors for lymph node metastasis in gallbladder carcinoma.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2013年第3期38-40,共3页 China Journal of Modern Medicine
关键词 胆囊癌 淋巴转移 危险因素 gallbladder carcinoma lymph metastasis risk factors
  • 相关文献

参考文献12

  • 1ESLICK GD. Epidemiology of gallbladder cancer[J]. Gastroenterol Clin North Am, 2010, 39(2): 307-330.
  • 2JAYARAMAN S, JARNAGIN WR. Management of gallbladder cancer[J]. Gastroenterol Clin North Am, 2010, 39(2): 331-342, .
  • 3ZHU AX, HONG TS, HEZEL AF, et at. Current management of gallbladder carcinoma[J]. Oncologist, 2010, 15(2): 168-181.
  • 4CIcIEN Y, CHEN Y, YU G, et al. Lymphangiogenic and angio- gentic microvessel density in gallbladder carcinoma[J]. Hepatogas- troenterology, 2011, 58(105): 20-25.
  • 5陈永标,江艺,张绍庚,吕立志,胡还章,林华.晚期胆囊癌的外科治疗(附40例分析)[J].中国现代医学杂志,2005,15(9):1418-1420. 被引量:2
  • 6Chinese KIM WS, CHOI DW, YOU DD, et al. Risk factors influencing recurrence, patterns of recmTence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma[J]. J Gastrointest Surg, 2010, 14(4): 679-687.
  • 7ITO K, ITO tt, ALLEN PJ, el at. Adequate lymph node assess- ment for extrahepatic bile duct adenocm'cinoma[J]. Ann Surg, 2010, 251(4): 675-681.
  • 8BISWAS PK. Carcinoma gallbladder[J] Mymensingh Med J, 2010, 19(3): 477-481.
  • 9SASAKI E, NAGINO M, EBATA T, et at. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in pa- tients with gallbladder carcinoma [J]. Ann Surg, 2006, 244(1): 99-105.
  • 10ITO H, ITO K, D'ANGELICA gallbladder cancer: implications M, et al. Accurate staging for for surgical therapy and patho- logical assessment[J]. Ann Surg, 2011, 254(2): 320-325.

二级参考文献7

共引文献1

同被引文献91

  • 1Naohiko Kohya,Kenji Kitahara,Kohji Miyazaki.Rational therapeutic strategy for T2 gallbladder carcinoma based on tumor spread[J].World Journal of Gastroenterology,2010,16(28):3567-3572. 被引量:10
  • 2刘允怡,赖俊雄.胆囊癌的发展及治疗[J].解放军医学杂志,2005,30(9):759-761. 被引量:12
  • 3斯东锋,全志伟.胆囊癌的分期与手术治疗[J].国际外科学杂志,2006,33(3):175-178. 被引量:6
  • 4LEE NK, KIM S, KIM TU, et al. Diffusion-weighted MRI for differentiation of benign from malignant lesions in the gallbladder [J]. Clinical Radiology, 2014, 69(2): e78-e85.
  • 5RODR IGUEZ-FERNANDEZ A, GOMEZ-R IO M, LLA- MAS-ELVIRA JM, et al. Positron-emission tomography with flu- orine-18-fluoro-2-deoxy-D-glucose for gallbladder cancer diag- nosis [J]. The American Journal of Surgery, 2004, 188 (2): 171-175.
  • 6LAZCANO-PONCE E C, MIQUEL J F, MUNOZ N, et al. Epi- demiology and molecular pathology of gallbladder cancer[J]. CA: A Cancer Journal for Clinicians, 2001, 51(6): 349-364.
  • 7MURATORE A, POLASTRI R, CAPUSSOTTI L. Radical surgery for gallbladder cancer: current options [J]. European Journal of Surgical Oncology (EJSO), 2000, 26(5): 438-443.
  • 8WAGHOLIKAR GD, BEHARI A, KRISHNANI N, et al. Early gallbladder cancer[J]. Journal of the American College of Sur- geons, 2002, 194(2): 137-141.
  • 9ROA I, DE ARETXABALA X, ARAYA J C, et al. Preneoplastic lesions in gallbladder cancer [J]. Journal of Surgical Oncology, 2006, 93(8): 615-623.
  • 10DESHMUKH SD, JOHNSON PT, SHETH S, et al. CT of gall- bladder cancer and its mimics: a pattern-based approach[J]. Ab- dominal Imaging, 2013, 38(3): 527-536.

引证文献13

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部